Skip to main content
Some US Hospitals Passing on Purchases of COVID Drug Some hospitals in the U.S. have been turning down part of their allocated supply of remdesivir, the COVID-19-fighting drug made by Gilead Sciences, the U.S. Health and Human Services Department confirmed Friday. From July 6 to September 8, state and territorial public health systems accepted about 72% of the remdesivir they were offered by HHS, a spokesperson confirmed Friday to Reuters. Hospitals then bought about two-thirds of what the states and territories accepted. The government has been leading the distribution of the drug, but that effort expires at the end of the month, and some hospitals are stockpiling remdesivir because they don’t know what the availability of the drug will be after September and want to be prepared if the pandemic flares this winter. Gilead did not respond to a request for comment from Reuters. Hospital say their supplies of the drug are adequate partly because they are only using it to treat the